Dicerna Pharmaceuticals Inc DRNA
We take great care to ensure that the data presented and summarized in this overview for Dicerna Pharmaceuticals Inc is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in DRNA
Top Purchases
Top Sells
About DRNA
Insider Transactions at DRNA
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2021
|
Shreeram Aradhye EVP & Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
6,973
-100.0%
|
$264,974
$38.25 P/Share
|
|
Dec 28
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
2,367
-100.0%
|
$89,946
$38.25 P/Share
|
|
Dec 28
2021
|
J Kevin Buchi Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
4,666
-100.0%
|
$177,308
$38.25 P/Share
|
|
Dec 28
2021
|
Robert D. Ciappenelli Chief Strategy Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
14,813
-100.0%
|
$562,894
$38.25 P/Share
|
|
Dec 28
2021
|
Stephen K Doberstein Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,333
-100.0%
|
$126,654
$38.25 P/Share
|
|
Dec 28
2021
|
Douglas Fambrough Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
231,431
-100.0%
|
$8,794,378
$38.25 P/Share
|
|
Dec 28
2021
|
Martin I Freed Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,333
-100.0%
|
$126,654
$38.25 P/Share
|
|
Dec 28
2021
|
Patrick M. Gray Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,333
-100.0%
|
$126,654
$38.25 P/Share
|
|
Dec 28
2021
|
Stephen J Hoffman Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
16,157
-100.0%
|
$613,966
$38.25 P/Share
|
|
Dec 28
2021
|
Marc D Kozin Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
5,000
-100.0%
|
$190,000
$38.25 P/Share
|
|
Dec 28
2021
|
Marc D Kozin Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,333
-100.0%
|
$240,654
$38.25 P/Share
|
|
Dec 28
2021
|
Douglas W. Pagan Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
7,775
-100.0%
|
$295,450
$38.25 P/Share
|
|
Dec 28
2021
|
Cynthia Smith Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,333
-100.0%
|
$126,654
$38.25 P/Share
|
|
Dec 28
2021
|
James B Weissman Chief Operating Officer & EVP |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
18,100
-100.0%
|
$687,800
$38.25 P/Share
|
|
Dec 28
2021
|
Ling Zeng Chief Legal Officer & Sec'y |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
5,032
-100.0%
|
$191,216
$38.25 P/Share
|
|
Dec 28
2021
|
Adam Koppel Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
3,080,237
-100.0%
|
$117,049,006
$38.25 P/Share
|
|
Dec 28
2021
|
Adam Koppel Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,333
-100.0%
|
$126,654
$38.25 P/Share
|
|
Dec 15
2021
|
Ling Zeng Chief Legal Officer & Sec'y |
SELL
Payment of exercise price or tax liability
|
Direct |
752
-13.0%
|
$28,576
$38.05 P/Share
|
|
Dec 15
2021
|
Ling Zeng Chief Legal Officer & Sec'y |
BUY
Exercise of conversion of derivative security
|
Direct |
2,562
+30.7%
|
-
|
|
Dec 15
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,675
-41.44%
|
$63,650
$38.05 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders